OPEN ENROLLMENT
A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis (PFI) (Also Known as Ledderhose Disease)
This study will assess the efficacy, safety, and tolerability of EN3835, an investigational treatment, compared to placebo in the treatment of PFI (also known as Ledderhose disease)….
- Investigator
- John Anderson, Jason Piraino
- IRB Number
- EN3835-309 PFI
- Ages
- 18 Years
- Sexes
- All
- Location
- Jacksonville
OPEN ENROLLMENT
Double Blind Placebo-Controlled Parallel Group Study of Safety and Efficacy of Isomyosamine in Treating Sarcopenia After Hip or Femoral Fracture in Gerontological Population
This study will involve about 60 people and will be conducted to investigate how well Isomyosamine helps people with sarcopenia (age-related loss of muscle) or frailty heal after breaking a bone….
- Investigator
- Porter Young
- IRB Number
- TNF001
- Ages
- 60 Years – 85 Years
- Sexes
- All
- Location
- Jacksonville
OPEN ENROLLMENT
REducing future fractureS and improving ouTcOmes of fRagility fracturE
The purpose of the Fracture Prevention Program is to evaluate methods for caring for patients after a recent bone break or fracture. Participants with a recent bone break, who have a…
- Investigator
- Porter Young
- IRB Number
- RESTORE
- Ages
- 50 Years – 100 Years
- Sexes
- All
- Location
- Jacksonville